National Health (Pharmaceutical Benefits – Therapeutic Groups) Amendment Determination 2018 (No. 1) (PB 27 of 2018) (Cth)

PB 27 of 2018

National Health (Pharmaceutical Benefits – Therapeutic Groups) Amendment Determination 2018 (No. 1)

National Health Act 1953

I, LISA LA RANCE, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this determination under subsection 84AG(1) of the National Health Act 1953.

Dated         26      March 2018

LISA LA RANCE

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

1. Name of Determination

(1)     This Determination is the National Health (Pharmaceutical Benefits – Therapeutic Groups) Amendment Determination 2018 (No. 1).

(2)     This Determination may also be cited as PB 27 of 2018.

1. Commencement

This Determination commences on 1 April 2018.

3              Amendments to PB 1 of 2010

Schedule 1 amends the National Health (Pharmaceutical Benefits – Therapeutic Groups) Determination 2010 (PB 1 of 2010).

Schedule 1             Amendments

[12]    Schedule 1, Part 2

omit:

5	Olmesartan
7	Valsartan